Verona Pharma Correlations
VRNA Stock | USD 64.17 1.78 2.85% |
The current 90-days correlation between Verona Pharma PLC and MoonLake Immunotherapeutics is 0.09 (i.e., Significant diversification). The correlation of Verona Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Verona Pharma Correlation With Market
Significant diversification
The correlation between Verona Pharma PLC and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Verona Pharma PLC and DJI in the same portfolio, assuming nothing else is changed.
Verona |
Moving together with Verona Stock
0.79 | VERV | Verve Therapeutics | PairCorr |
0.67 | FENC | Fennec Pharmaceuticals | PairCorr |
0.63 | CUE | Cue Biopharma | PairCorr |
0.89 | OPT | Opthea Earnings Call Today | PairCorr |
0.78 | GANX | Gain Therapeutics | PairCorr |
0.8 | LTRN | Lantern Pharma | PairCorr |
0.86 | PHGE | Biomx Inc | PairCorr |
Moving against Verona Stock
0.88 | INZY | Inozyme Pharma | PairCorr |
0.79 | ILMN | Illumina | PairCorr |
0.76 | FATE | Fate Therapeutics | PairCorr |
0.76 | NVO | Novo Nordisk AS | PairCorr |
0.74 | NTLA | Intellia Therapeutics | PairCorr |
0.69 | EXAS | EXACT Sciences | PairCorr |
0.62 | KURA | Kura Oncology | PairCorr |
0.41 | EDIT | Editas Medicine Earnings Call Today | PairCorr |
0.39 | INAB | In8bio Inc | PairCorr |
0.34 | NAMSW | NewAmsterdam Pharma | PairCorr |
0.91 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.91 | CRBU | Caribou Biosciences | PairCorr |
0.9 | ADTX | Aditxt Inc | PairCorr |
0.9 | TERN | Terns Pharmaceuticals | PairCorr |
0.9 | CRNX | Crinetics Pharmaceuticals Earnings Call Today | PairCorr |
0.84 | TCRX | Tscan Therapeutics | PairCorr |
0.75 | REGN | Regeneron Pharmaceuticals | PairCorr |
0.73 | CTMX | CytomX Therapeutics | PairCorr |
0.7 | STRO | Sutro Biopharma | PairCorr |
0.67 | DAWN | Day One Biopharmaceu | PairCorr |
0.32 | ANAB | AnaptysBio | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Verona Stock performing well and Verona Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Verona Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
VTYX | 4.52 | (0.05) | 0.00 | (0.05) | 0.00 | 11.35 | 35.02 | |||
IDYA | 2.28 | (0.32) | 0.00 | 7.20 | 0.00 | 4.37 | 13.32 | |||
PTGX | 2.27 | (0.19) | 0.00 | (0.15) | 0.00 | 3.48 | 18.65 | |||
SNDX | 2.27 | (0.05) | 0.00 | (0.10) | 0.00 | 5.59 | 12.74 | |||
DAWN | 1.83 | (0.13) | 0.00 | (0.30) | 0.00 | 3.92 | 10.17 | |||
XFOR | 7.37 | 0.88 | 0.10 | (0.48) | 7.11 | 26.42 | 68.45 | |||
INZY | 4.08 | (1.20) | 0.00 | 0.79 | 0.00 | 7.72 | 38.13 | |||
ABOS | 2.87 | (0.72) | 0.00 | (0.62) | 0.00 | 6.70 | 15.46 | |||
MREO | 2.78 | (0.36) | 0.00 | (0.38) | 0.00 | 6.16 | 20.77 | |||
TERN | 3.21 | (0.67) | 0.00 | 0.53 | 0.00 | 5.17 | 26.61 |
Verona Pharma Corporate Management
Caroline Diaz | Senior Affairs | Profile | |
LCSW BA | G Counsel | Profile | |
Matthew Casbon | Marketing Sales | Profile | |
Peter Spargo | Senior Controls | Profile | |
Kathleen MD | Chief Officer | Profile | |
B ASIA | General Counsel | Profile |